CERPOP, Toulouse University, Inserm - Paul Sabatier University, Toulouse, France.
Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France.
Orphanet J Rare Dis. 2021 Jul 8;16(1):305. doi: 10.1186/s13023-021-01930-1.
Adolescents with idiopathic scoliosis display high ghrelin levels. As hyperghrelinemia is found in patients with PWS and early-onset scoliosis (EOS) is highly prevalent in these patients, our aims were to explore (1) whether ghrelin levels differ between those with and without EOS and correlate with scoliosis severity, and (2) whether ghrelin levels in the first year of life are associated with the later development of EOS.
We used a case control study design for the first question and a longitudinal design for the second. Patients with PWS having plasma ghrelin measurements recorded between 2013 and 2018 in our database were selected and 30 children < 10 years old with EOS and 30 age- and BMI-matched controls without EOS were included. The Cobb angle at diagnosis was recorded. In addition, 37 infants with a ghrelin measurement in the first year of life were followed until 4 years of age and assessed for EOS. Total ghrelin (TG), acylated (AG) and unacylated ghrelin (UAG), and the AG/UAG ratio were analyzed.
EOS children had an AG/UAG ratio statistically significantly lower than controls. The Cobb angle was positively correlated with TG and UAG. TG and AG in the first year of life were higher in infants who later develop EOS without reaching a statistically significant difference.
Our results suggest that ghrelin may play a role in the pathophysiology of EOS in PWS. Higher ghrelinemia in the first year of life required careful follow-up for EOS.
特发性脊柱侧凸的青少年表现出较高的生长激素释放肽水平。由于肥胖症患者存在高促生长素血症,且这些患者中早期发病的脊柱侧凸(EOS)发病率很高,我们的目的是探讨:(1)是否存在 EOS 患者和无 EOS 患者的生长激素释放肽水平存在差异,以及该水平与脊柱侧凸严重程度的相关性;(2)生命第一年的生长激素释放肽水平是否与之后 EOS 的发展相关。
我们使用病例对照研究设计来回答第一个问题,使用纵向设计来回答第二个问题。我们从数据库中选择了在 2013 年至 2018 年间有血浆生长激素释放肽测量值的肥胖症患者,并纳入了 30 名年龄<10 岁且患有 EOS 的儿童和 30 名年龄和 BMI 匹配的无 EOS 对照儿童。记录诊断时的 Cobb 角。此外,对 37 名在生命第一年有生长激素释放肽测量值的婴儿进行了随访,直到 4 岁,并评估是否发生 EOS。分析总生长激素释放肽(TG)、酰化(AG)和非酰化生长激素释放肽(UAG)以及 AG/UAG 比值。
EOS 患儿的 AG/UAG 比值明显低于对照组。Cobb 角与 TG 和 UAG 呈正相关。在生命的第一年,后来发生 EOS 的婴儿的 TG 和 AG 更高,但未达到统计学显著差异。
我们的结果表明,生长激素释放肽可能在肥胖症患者的 EOS 病理生理学中起作用。生命第一年的高生长激素释放肽血症需要对 EOS 进行密切随访。